A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension

David A Godfrey1, Lee S Peplinski2, Jeanette A Stewart3, William C Stewart31Glaucoma Associates of Texas, Dallas, TX, USA; 2Kentuckiana Institute for Eye Research, Louisville, KY, USA; 3PRN Pharmaceutical Research Network, LLC, Dallas, TX, USAPurpose: To determine the short-term comfort after a sing...

Full description

Bibliographic Details
Main Authors: David A Godfrey, Lee S Peplinski, Jeanette A Stewart, William C Stewart
Format: Article
Language:English
Published: Dove Medical Press 2009-01-01
Series:Clinical Ophthalmology
Online Access:http://www.dovepress.com/a-comfort-comparison-of-travoprost-bak-free-0004-versus-latanoprost-00-a2822
id doaj-9c415153b98b461bb0fe2a32383eb58b
record_format Article
spelling doaj-9c415153b98b461bb0fe2a32383eb58b2020-11-24T22:23:15ZengDove Medical PressClinical Ophthalmology1177-54671177-54832009-01-012009default189194A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertensionDavid A GodfreyLee S PeplinskiJeanette A StewartWilliam C StewartDavid A Godfrey1, Lee S Peplinski2, Jeanette A Stewart3, William C Stewart31Glaucoma Associates of Texas, Dallas, TX, USA; 2Kentuckiana Institute for Eye Research, Louisville, KY, USA; 3PRN Pharmaceutical Research Network, LLC, Dallas, TX, USAPurpose: To determine the short-term comfort after a single dose of travoprost BAK-free compared to latanoprost in primary open-angle glaucoma or ocular hypertensive patients.Design: Prospective, double-masked, randomized comparison of two separate active agents dosed once in opposite eyes.Methods: At Visit 1, qualified patients began a glaucoma medicine-free period for three days. At Visit 2, patients were randomly assigned to travoprost BAK-free or latanoprost in opposite eyes. Following dosing in each eye, patients completed a visual analog scale (VAS score, 0–100 mm) at specified time intervals and a comfort survey.Results: In 54 completed subjects, no difference existed five seconds after dosing, in comfort on the VAS between latanoprost (7.1 ± 16.2 mm) and travoprost BAK-free (7.8 ± 16.1 mm, P = 0.53). Also no differences existed between treatments following dosing for discomfort at individual timepoints past five seconds, peak discomfort or the time required to return to baseline comfort (P > 0.05). In addition, the comfort survey demonstrated no difference between products for burning, stinging, foreign body sensation, overall comfort and general acceptance between the products, both for absolute levels and changes from baseline (P > 0.05).Conclusion: Following a single instillation, both latanoprost and travoprost BAK-free exhibit similar comfort scores.Keywords: comfort, travoprost BAK-free, latanoprost, glaucoma, ocular hypertension http://www.dovepress.com/a-comfort-comparison-of-travoprost-bak-free-0004-versus-latanoprost-00-a2822
collection DOAJ
language English
format Article
sources DOAJ
author David A Godfrey
Lee S Peplinski
Jeanette A Stewart
William C Stewart
spellingShingle David A Godfrey
Lee S Peplinski
Jeanette A Stewart
William C Stewart
A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
Clinical Ophthalmology
author_facet David A Godfrey
Lee S Peplinski
Jeanette A Stewart
William C Stewart
author_sort David A Godfrey
title A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
title_short A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
title_full A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
title_fullStr A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
title_full_unstemmed A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
title_sort comfort comparison of travoprost bak-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
publisher Dove Medical Press
series Clinical Ophthalmology
issn 1177-5467
1177-5483
publishDate 2009-01-01
description David A Godfrey1, Lee S Peplinski2, Jeanette A Stewart3, William C Stewart31Glaucoma Associates of Texas, Dallas, TX, USA; 2Kentuckiana Institute for Eye Research, Louisville, KY, USA; 3PRN Pharmaceutical Research Network, LLC, Dallas, TX, USAPurpose: To determine the short-term comfort after a single dose of travoprost BAK-free compared to latanoprost in primary open-angle glaucoma or ocular hypertensive patients.Design: Prospective, double-masked, randomized comparison of two separate active agents dosed once in opposite eyes.Methods: At Visit 1, qualified patients began a glaucoma medicine-free period for three days. At Visit 2, patients were randomly assigned to travoprost BAK-free or latanoprost in opposite eyes. Following dosing in each eye, patients completed a visual analog scale (VAS score, 0–100 mm) at specified time intervals and a comfort survey.Results: In 54 completed subjects, no difference existed five seconds after dosing, in comfort on the VAS between latanoprost (7.1 ± 16.2 mm) and travoprost BAK-free (7.8 ± 16.1 mm, P = 0.53). Also no differences existed between treatments following dosing for discomfort at individual timepoints past five seconds, peak discomfort or the time required to return to baseline comfort (P > 0.05). In addition, the comfort survey demonstrated no difference between products for burning, stinging, foreign body sensation, overall comfort and general acceptance between the products, both for absolute levels and changes from baseline (P > 0.05).Conclusion: Following a single instillation, both latanoprost and travoprost BAK-free exhibit similar comfort scores.Keywords: comfort, travoprost BAK-free, latanoprost, glaucoma, ocular hypertension
url http://www.dovepress.com/a-comfort-comparison-of-travoprost-bak-free-0004-versus-latanoprost-00-a2822
work_keys_str_mv AT davidagodfrey acomfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension
AT leespeplinski acomfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension
AT jeanetteastewart acomfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension
AT williamcstewart acomfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension
AT davidagodfrey comfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension
AT leespeplinski comfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension
AT jeanetteastewart comfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension
AT williamcstewart comfortcomparisonoftravoprostbakfree0004versuslatanoprost0005inpatientswithprimaryopenangleglaucomaorocularhypertension
_version_ 1725765147292598272